NRS
Neville Rodie & Shaw Portfolio holdings
AUM $1.35B
1-Year Return
18.75%
This Quarter Return
+1.47%
1 Year Return
+18.75%
3 Year Return
+74.72%
5 Year Return
+143.89%
10 Year Return
+320.69%
AUM
$1.37B
AUM Growth
+$12.7M
(+0.93%)
Cap. Flow
+$12.9M
Cap. Flow
% of AUM
0.94%
Top 10 Holdings %
Top 10 Hldgs %
38.99%
Holding
271
New
23
Increased
77
Reduced
83
Closed
11
Top Buys
| 1 |
Vertiv
VRT
|
+$2.91M |
| 2 |
Bank of New York Mellon
BK
|
+$1.73M |
| 3 |
State Street
STT
|
+$1.37M |
| 4 |
Microsoft
MSFT
|
+$1.29M |
| 5 |
JPMorgan Chase
JPM
|
+$1M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$2.33M |
| 2 |
CVS Health
CVS
|
+$1.9M |
| 3 |
Apple
AAPL
|
+$1.86M |
| 4 |
ON Semiconductor
ON
|
+$917K |
| 5 |
AbbVie
ABBV
|
+$761K |
Sector Composition
| 1 | Technology | 28.17% |
| 2 | Industrials | 14.48% |
| 3 | Healthcare | 13.98% |
| 4 | Financials | 13.9% |
| 5 | Communication Services | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Truist Financial
TFC
$57.8B
| $1.63M | 0.12% |
37,468
+5,695
| +18% | +$247K |
|
102
PNC Financial Services
PNC
$79.8B
| $1.56M | 0.11% |
8,077
+150
| +2% | +$28.9K |
|
103
Edwards Lifesciences
EW
$44.6B
| $1.5M | 0.11% |
20,322
| – | – |
|
104
Cisco
CSCO
$264B
| $1.49M | 0.11% |
25,195
+16,112
| +177% | +$953K |
|
105
Carrier Global
CARR
$52.1B
| $1.47M | 0.11% |
21,589
+31
| +0.1% | +$2.12K |
|
106
Trane Technologies
TT
$89.6B
| $1.41M | 0.1% |
3,805
| – | – |
|
|
GAM
107
General American Investors Company
GAM
$1.43B
| $1.38M | 0.1% |
27,065
| – | – |
|
108
Berkshire Hathaway Class A
BRK.A
$1.06T
| $1.36M | 0.1% |
2
| – | – |
|
109
Intel
INTC
$116B
| $1.36M | 0.1% |
67,910
+13,095
| +24% | +$262K |
|
110
Gilead Sciences
GILD
$140B
| $1.36M | 0.1% |
14,726
-125
| -0.8% | -$11.5K |
|
111
Nike
NKE
$108B
| $1.36M | 0.1% |
17,958
-1,693
| -9% | -$128K |
|
112
AT&T
T
$212B
| $1.34M | 0.1% |
58,775
+28,262
| +93% | +$643K |
|
113
W.W. Grainger
GWW
$48.5B
| $1.32M | 0.1% |
1,254
-35
| -3% | -$36.9K |
|
114
Philip Morris
PM
$252B
| $1.27M | 0.09% |
10,580
| – | – |
|
115
Veralto
VLTO
$26.8B
| $1.25M | 0.09% |
12,255
-121
| -1% | -$12.3K |
|
116
US Bancorp
USB
$76.7B
| $1.19M | 0.09% |
24,777
+4,951
| +25% | +$237K |
|
117
Marsh & McLennan
MMC
$97.3B
| $1.18M | 0.09% |
5,530
| – | – |
|
118
Colgate-Palmolive
CL
$66.4B
| $1.1M | 0.08% |
12,130
| – | – |
|
119
DuPont de Nemours
DD
$32.3B
| $1.08M | 0.08% |
14,126
+120
| +0.9% | +$9.15K |
|
120
Otis Worldwide
OTIS
$35.2B
| $1.07M | 0.08% |
11,558
| – | – |
|
121
Stryker
SYK
$144B
| $1.03M | 0.08% |
2,866
| – | – |
|
122
Heartland Express
HTLD
$660M
| $971K | 0.07% |
86,501
-2,858
| -3% | -$32.1K |
|
123
Fortive
FTV
$16.5B
| $970K | 0.07% |
12,933
| – | – |
|
124
Cigna
CI
$79.4B
| $948K | 0.07% |
3,435
| – | – |
|
125
Golub Capital BDC
GBDC
$3.75B
| $947K | 0.07% |
62,463
+7,906
| +14% | +$120K |
|